Lucentis® using visudyne® study: Determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration

Eric Chen, David M. Brown, Tien P. Wong, Matthew S. Benz, Eric Kegley, Joel Cox, Richard H. Fish, Rosa Y. Kim

Research output: Contribution to journal › Article › peer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'Lucentis® using visudyne® study: Determining the threshold-dose fluence of verteporfin photodynamic therapy combined with intravitreal ranibizumab for exudative macular degeneration'. Together they form a unique fingerprint.

Medicine & Life Sciences